Policy Papers

  • The MITA Smart Dose standard identifies four key CT equipment features that enable optimization of radiation dose delivery without compromising the quality images necessary for an accurate diagnosis. The US Food and Drug Administration (FDA) and patient health organizations Image Gently and Image Wisely applauded MITA’s announcement of this important standard. Automatic Exposure Control Clinicians Read More

  • Advances in medical imaging technology continuously improve the delivery of healthcare to patients. Given rising healthcare costs and the need to responsibly steward financial resources, this paper highlights scientific, peer-reviewed studies that demonstrate improved patient outcomes (including survival and quality of life) and cost savings associated with various imaging technologies.

  • Diagnostic ultrasound has multiple uses in today’s clinical practice being used for primary diagnosis and monitoring of known conditions to guidance of minimally invasive surgical procedures.

  • Medical imaging tests are central to modern patient-care. They ensure that life-threatening health
    conditions are caught early and Medicare beneficiaries can be treated sooner. This prevents the
    need for more invasive, and often more costly, diagnostic procedures as well as the monetary and
    emotional costs due to late-stage diagnosis.

  • Radiation oncology is a cornerstone of cancer therapy offering highly personalized, non-invasive and cost-effective care for 50-60% of all diagnosed cancer patients. With an estimated 1.4 million Americans diagnosed with cancer in 2008 alone, and malignancies claiming over half a million lives, access to radiation therapy is essential for ensuring high quality cancer care.

  • List of dose reduction features for the following CT manufacturers: GE Healthcare, Hitachi Medical Systems, NeuroLogica, Neusoft Medical Systems, Philips Healthcare, Siemens Medical Solutions,Toshiba America Medical Systems…

  • MITA’s 2011 positions on Medical Device User Fee Act (MDUFA) Negotiations, Reimbursement for Imaging and Radiation Therapy Services, Medical Device Tax, Medical Radiation

  • Health care providers and patients understand that the key to improving our health care system lies in promoting medical innovation…

  • Medical device manufacturers, patient groups, and the FDA have long agreed that reforms to the 510(k) device clearance process have the potential to benefit patients and spur innovation…

  • Despite widely accepted evidence that imaging services provide considerable value in a cost effective manner, the Department of Health and Human Services (HHS), Congress, MedPAC and Government Accountability Office (GAO) continue to mislabel medical imaging as a leading factor in the increasing costs of Medicare.